 MENLO PARK, Calif. and SINGAPORE., Jan. 06, 2022 GLOBE NEWSWIRE -- ASLAN Pharmaceuticals Nasdaq:ASLN, a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that Dr Carl Firth, CEO, is scheduled to give a company presentation at the H.C. Wainwright Bioconnect Conference on January 10, 2022. The conference will be held virtually from January 10 to January 13, 2022. 